Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study

Journal of Diabetes Research
Khalid SheikhDaniel J DeSalvo

Abstract

The purpose of this cross-sectional study was to determine the rates of diabetes device use (insulin pump and continuous glucose monitor (CGM)) and association with glycemic control in youth with type 1 diabetes in a large, diverse pediatric center. Demographic and clinical data were obtained from 1992 patients who met the eligibility criteria (age < 26 years, diabetes duration ≥ 1 year, and ≥1 clinic visit in the preceding 12 months). Statistical analyses assessed the likelihood of device use based on demographic characteristics and the association between device use and glycemic control based on most recent hemoglobin A1c (HbA1c). Mean age was 13.8 ± 4.2 years, 50.7% were female, diabetes duration was 6.2 ± 4 years, and mean HbA1c was 8.7 ± 1.8%. Overall, 38.2% of patients were on pump therapy and 18.5% were on CGM. Patients who were non-Hispanic (NH) white, privately insured, and with primary English-speaking parent(s) had higher rates of insulin pump use, as well as CGM use (P < 0.001 for both). Female patients had higher rates of pump use only (P < 0.01). Private health insurance, NH white race/ethnicity, and CGM use were each associated with lower HbA1c (P = 0.03, <0.001, and <0.008, resp.). At a large, diverse, pediatric...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Sep 10, 2008·The New England Journal of Medicine·William V TamborlaneDongyuan Xing
May 12, 2009·Diabetes Care·UNKNOWN Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study GroupDongyuan Xing
Mar 9, 2011·Diabetes Research and Clinical Practice·Soohyun NamSusan L Janson
Apr 27, 2012·The New England Journal of Medicine·John C Pickup
Aug 15, 2013·Current Diabetes Reports·Daniel DeSalvo, Bruce Buckingham
Feb 15, 2014·The Cochrane Database of Systematic Reviews·Birgit FullertonAndrea Siebenhofer
Jun 18, 2014·Diabetes Care·Jane L ChiangUNKNOWN Type 1 Diabetes Sourcebook Authors
Feb 18, 2015·Pediatrics·Steven M WilliUNKNOWN T1D Exchange Clinic Network
May 23, 2015·Diabetes Care·Kellee M MillerUNKNOWN T1D Exchange Clinic Network
Jul 15, 2015·Pediatric Diabetes·Mark A ClementsUNKNOWN T1D Exchange Clinic Network
Feb 18, 2016·Journal of Diabetes Science and Technology·David AhnSteven Edelman
Jun 6, 2017·Diabetes Technology & Therapeutics·Persis V CommissariatLori M Laffel
Oct 2, 2017·Diabetes Research and Clinical Practice·David C KlonoffAndjela Drincic
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jun 9, 2020·Pediatric Diabetes·Ashley M ButlerAshley E Teasdale
Nov 7, 2019·Current Diabetes Reports·Leslie EilandAndjela Drincic
Nov 1, 2020·The Journal of Pediatrics·Christine A MarchIngrid M Libman
Jul 8, 2021·Pediatric Diabetes·Elise Schlissel TremblayKatharine Garvey
Aug 24, 2021·Clinical Diabetes : a Publication of the American Diabetes Association·Ran SunTina Hernandez-Boussard
Dec 16, 2021·The Journal of Clinical Endocrinology and Metabolism·Kael WherryRobert A Vigersky
Jan 28, 2022·Diabetes Technology & Therapeutics·Shana R MencherLois S Sadler

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.